Medovex aims to help fight the opioid crisis with its DenerveX system

Late last month, the White House issued a statement declaring the opioid crisis a national health emergency. Many companies in the healthcare field are aware of this issue, but only a handful of pain-treating device makers are focused on fighting the crisis. Atlanta-based Medovex is aiming to be one of the few. Medovex produces the DenerveX system, a combined therapy device designed to treat patients with chronic lower back pain related to facet joint syndrome. It’s a system that prez & CEO Patrick Kullman is hopeful will both be successful and help stem the opioid crisis in the US. “We have made a creative new breakthrough technology to directly treat a condition called facet joint syndrome, and it is a very large market globally, affecting about 31% of the 10% adult population in the United States, Europe, and Asia,” Kullman said in an interview with MassDevice.com. Facet joint syndrome is an osteo-arthritis-related disease that is mainly treated with opioids, according to Kullman. Approximately 40% of patients with chronic lower back pain are treated with pain killers, he clarified, with the most common pain killer being an opiate-class drug. But Kullman and his team at Medovex are hopeful that the DenerveX device could help to fight the opioid crisis as the treatment has been shown to reduce pain as well as opioid consumption over a long period of time. “It is a really, really big issue. And we have a device with a mechanical and thermal metho...
Source: Mass Device - Category: Medical Devices Authors: Tags: Pain Management Spinal Medovex Source Type: news